BR31

Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC

 
Click here for information
   
 

                     

Immunotherapy  

If you have any questions,  please contact:

Deb Lewis
Clinical Research Coordinator
LHSC Victoria Hospital
E2-003
(519) 685-8500 ext 75685
deb.lewis@lhsc.on.ca

LHSCResearch & Training

Last Updated November 17, 2016 | © 2007, LHSC, London Ontario Canada